Evidence map›Paper›PMID 28467930›Full record

ArticleCell metabolism2017

DNA-PK Promotes the Mitochondrial, Metabolic, and Physical Decline that Occurs During Aging.

Sung-Jun Park, Oksana Gavrilova, Alexandra L Brown, Jamie E Soto, Shannon Bremner, Jeonghan Kim, Xihui Xu, Shutong Yang, Jee-Hyun Um, Lauren G Koch and 8 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Cell metabolism, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 126 citations in OpenAlex.

  1. Trial
  2. Article
  3. Improving our understanding of the biology of aging: findings from the Age-It Research Program.The journals of gerontology. Series B, Psychological sciences and social sciences · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Upstream targeting for the prevention of atrial fibrillation: Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF)-rationale and study design.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2025
    Article
  11. Article
  12. Secrets of DNA-PKcs beyond DNA repair.NPJ precision oncology · 2024
    Review
  13. Article
  14. Article
  15. Differential genetic expression within reward-specific ensembles in mice.bioRxiv : the preprint server for biology · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Impaired end joining induces cardiac atrophy in a Hutchinson-Gilford progeria mouse model.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 1 country.

Sung-Jun ParkLaboratory of Obesity and Aging Research, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Oksana GavrilovaMouse Metabolism Core, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Alexandra L BrownLaboratory of Obesity and Aging Research, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Jamie E SotoProgram in Molecular Medicine and Division of Endocrinology, Metabolism and Diabetes, University of Utah School of Medicine, Salt Lake City, UT 84112, USA; Fraternal Order of Eagles Diabetes Research Center and Division of Endocrinology and Metabolism, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
Shannon BremnerDepartment of Orthopedic Surgery, University of California and V.A. Medical Centers, San Diego, La Jolla, CA 92093, USA.
Jeonghan KimLaboratory of Obesity and Aging Research, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Xihui XuLaboratory of Obesity and Aging Research, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Shutong YangLaboratory of Obesity and Aging Research, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Jee-Hyun UmLaboratory of Obesity and Aging Research, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Lauren G KochDepartment of Anesthesiology, The University of Michigan, Ann Arbor, MI 48109, USA.
Steven L BrittonDepartment of Anesthesiology, The University of Michigan, Ann Arbor, MI 48109, USA; Department of Molecular & Integrative Physiology, The University of Michigan, Ann Arbor, MI 48109, USA.
Richard L LieberDepartment of Orthopedic Surgery, University of California and V.A. Medical Centers, San Diego, La Jolla, CA 92093, USA.
Andrew PhilpDepartment of Physiology and Membrane Biology, University of California Davis, Davis, CA USA 95616.
Keith BaarDepartment of Physiology and Membrane Biology, University of California Davis, Davis, CA USA 95616.
Steven G KohamaDivision of Neuroscience, Oregon National Primate Research Center, Oregon Health and Sciences University, Portland, OR 97239, USA.
E Dale AbelProgram in Molecular Medicine and Division of Endocrinology, Metabolism and Diabetes, University of Utah School of Medicine, Salt Lake City, UT 84112, USA; Fraternal Order of Eagles Diabetes Research Center and Division of Endocrinology and Metabolism, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
Myung K KimLaboratory of Obesity and Aging Research, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Jay H ChungLaboratory of Obesity and Aging Research, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: chungj@nhlbi.nih.gov.
National Institutes of Health · USNational Heart Lung and Blood Institute · USUniversity of California, Davis · USUniversity of Michigan–Ann Arbor · USNational Institute of Diabetes and Digestive and Kidney Diseases · USOregon National Primate Research Center · USUniversity of Iowa · USUniversity of Utah · US

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
Stress response and energy metabolism as a function of agingZIAHL006119 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI CHUNG, JAY H · 2011 to 2025
$33.9M
Metabolic Studies of Mouse Models of Obesity and DiabetesZICDK070002 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI GAVRILOVA, OKSANA · 2009 to 2025
$15.0M
Treatment for obesityZIAHL006118 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI CHUNG, JAY H · 2011 to 2019
$11.2M
Insulin resistance and cardiac dysfunction in obesityR01HL073167 · NHLBI · UNIVERSITY OF UTAH · PI ABEL, EVAN DALE · 2003 to 2007
$2.0M
Resource for Rat Genetic Models of Aerobic CapacityP40OD021331 · OD · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI KOCH, LAUREN GERARD · 2015 to 2019
$1.9M
Intramural NIH HHS ZIA HL006118NHLBI NIH HHS R01 HL073167NIH HHS P40 OD021331NIH HHS P51 OD011092
6 · The paper itself

Abstract

Hallmarks of aging that negatively impact health include weight gain and reduced physical fitness, which can increase insulin resistance and risk for many diseases, including type 2 diabetes. The underlying mechanism(s) for these phenomena is poorly understood. Here we report that aging increases DNA breaks and activates DNA-dependent protein kinase (DNA-PK) in skeletal muscle, which suppresses mitochondrial function, energy metabolism, and physical fitness. DNA-PK phosphorylates threonines 5 and 7 of HSP90α, decreasing its chaperone function for clients such as AMP-activated protein kinase (AMPK), which is critical for mitochondrial biogenesis and energy metabolism. Decreasing DNA-PK activity increases AMPK activity and prevents weight gain, decline of mitochondrial function, and decline of physical fitness in middle-aged mice and protects against type 2 diabetes. In conclusion, DNA-PK is one of the drivers of the metabolic and fitness decline during aging, and therefore DNA-PK inhibitors may have therapeutic potential in obesity and low exercise capacity.

Indexed as

AgingEnergy MetabolismAMP-Activated Protein KinasesAnimalsBenzofuransDiabetes Mellitus, Type 2DNA-Activated Protein KinaseMacaca mulattaMice, SCIDMitochondria, MuscleMuscle, SkeletalPhysical Conditioning, AnimalQuinolinesRats(3aS,4S,9bS)-N-(2-(8-cyano-1-formyl-2,3,3a,4,5,9b-hexahydro-1H-pyrrolo(3,2-c)quinolin-4-yl)-2-methylpropyl)-4,6-difluorobenzofuran-2-carboxyamideAMP-Activated Protein KinasesBenzofuransDNA-Activated Protein KinaseQuinolinesagingAMPKcalorie restrictionDNA-PKexerciseHSP90αinsulin sensitivitymitochondriaobesityskeletal muscletype 2 diabetes

Identifiers

PMID28467930
PMCPMC5485859
OpenAlexW2611152592

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.